-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Cls9ITfyD6sFc0sPLzIMKY6q9wt8xpYUXZDF2SsPZ7GWlhS0z0IEXM2r6UF8rpM5 3Z3YQ/ZsGkJtgb9icZsobw== 0000946486-05-000011.txt : 20050323 0000946486-05-000011.hdr.sgml : 20050323 20050323085736 ACCESSION NUMBER: 0000946486-05-000011 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050321 FILED AS OF DATE: 20050323 DATE AS OF CHANGE: 20050323 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DISCOVERY LABORATORIES INC /DE/ CENTRAL INDEX KEY: 0000946486 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943171943 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 350 MAIN STREET SUITE 307 CITY: DOYLESTOWN STATE: PA ZIP: 18901 BUSINESS PHONE: 2152404699 MAIL ADDRESS: STREET 1: 350 MAIN STREET SUITE 307 CITY: DOYLESTOWN STATE: PA ZIP: 18901 FORMER COMPANY: FORMER CONFORMED NAME: ANSAN PHARMACEUTICALS INC DATE OF NAME CHANGE: 19961121 FORMER COMPANY: FORMER CONFORMED NAME: ANSAN INC DATE OF NAME CHANGE: 19950609 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LOPEZ DAVID L CENTRAL INDEX KEY: 0001283889 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26422 FILM NUMBER: 05697969 BUSINESS ADDRESS: STREET 1: 350 S MAIN ST STREET 2: STE 307 CITY: DOYLESTOWN STATE: PA ZIP: 18901 BUSINESS PHONE: 2153404699X140 4 1 edgardoc.xml PRIMARY DOCUMENT X0202 4 2005-03-21 0 0000946486 DISCOVERY LABORATORIES INC /DE/ DSCO 0001283889 LOPEZ DAVID L 2600 KELLY ROAD WARRINGTON PA 18976 0 1 0 0 Senior VP & Legal Counsel Common Stock 2004-10-22 5 A 0 243 6.7 A 4123 D Common Stock 2005-02-15 5 A 0 221 7.337 A 4344 D Common Stock 2005-03-21 4 P 0 6000 5.684 A 10344 D Transaction reported on Table I represents Issuer's matching stock contribution pursuant to 401(k) plan. David L. Lopez, Esquire 2005-03-23 -----END PRIVACY-ENHANCED MESSAGE-----